Skip to main content

Table 3 Number of DTCs detected before (BM2) and after docetaxel treatment (BM3/BM4) in BM2-positive patients a

From: Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study

Number of DTCs BM2 Number (%) BM3 Number (%) BM4 Number (%) Last post-treatment BM result Number (%)
0   59 (83.1) 53b (82.8) 57 (79.2)
1 39 (54.1) 7 (9.9) 9 (14.1) 9 (12.5)
2 16 (22.2) 1 (1.4) 1 (1.6) 2 (2.8)
≥3 17 (23.6) 4 (5.6) 1 (1.6) 4 (5.6)
Not performed   1 8  
  1. aOnly patients with DTC results at BM3 and/or BM4 are included (see Figure 1).
  2. bThree samples classified as negative with morphologically similar cells detected in the corresponding negative control.